Price Alert

QuidelOrtho Corporation (QDEL)

NASDAQ: QDEL · Real-Time Price · USD

30.47

-1.46 (-4.57%)

At close: Oct 03, 2025, 2:27 PM

-4.57% (1D)

Bid	30.42
Market Cap	2.07B
Revenue (ttm)	2.74B
Net Income (ttm)	-466.4M
EPS (ttm)	-7.11
PE Ratio (ttm)	-4.29
Forward PE	10.18
Analyst	Buy
Dividends	n/a

Ask	30.52
Volume	1,381,254
Avg. Volume (20D)	1,402,351.7
Open	32.07
Previous Close	31.93
Day's Range	29.70 - 32.81
52-Week Range	22.05 - 49.45
Beta	0.15
Ex-Dividend Date	n/a

About QDEL

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol QDEL

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for QDEL stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Next Earnings Release

QuidelOrtho Corporation is scheduled to release its earnings on Nov 6, 2025, after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription

Why Price Moved

1 month ago

-1.01%

QDEL stock has given up its prior gain. QuidelOrth... Unlock content with Pro Subscription

1 month ago

-1.01%

QuidelOrtho shares are trading higher after the company reported better-than-expected Q2 financial results.

News

2 days ago · zacks.com

QuidelOrtho Expands Portfolio With the Launch of FDA-Approved Test

QDEL boosts its respiratory testing lineup with the FDA-cleared QUICKVUE Influenza + SARS Test for professional use.

1 month ago · zacks.com

Why QuidelOrtho (QDEL) is a Top Growth Stock for the Long-Term

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

1 month ago · zacks.com

Should Value Investors Buy QuidelOrtho (QDEL) Stock?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest...

1 month ago · zacks.com

QuidelOrtho Stock Gains Following Q2 Earnings Beat, Margins Expand

QDEL stock rises 12.8% after Q2 earnings beat. Adjusted margins improve amid soft revenue and ongoing business headwinds.

1 month ago · seekingalpha.com

QuidelOrtho Corporation (QDEL) Q2 2025 Earnings Call Transcript

QuidelOrtho Corporation (NASDAQ:QDEL ) Q2 2025 Earnings Conference Call August 5, 2025 5:00 PM ET Company Participants Brian J. Blaser - President, CEO & Director Joseph M.